FORT MYERS — Cancer-testing lab NeoGenomics launched a new line of liquid biopsy tests that the firm says can reduce the need for bone marrow biopsies through next-generation sequencing and other advanced molecular technologies.
Continue reading your article with a Business Observer subscription.
What's included:
✓ Unlimited digital access to BusinessObserverFL.com
✓ E-Newspaper app, digital replica of print edition